Management of low-grade glioma: a systematic review and meta-analysis

…, PD Brown, E Maher, D Aregawi… - Neuro-oncology …, 2019 - academic.oup.com
Background Optimum management of low-grade gliomas remains controversial, and widespread
practice variation exists. This evidence-based meta-analysis evaluates the association …

[HTML][HTML] Neutrophil-induced ferroptosis promotes tumor necrosis in glioblastoma progression

…, K Thamburaj, MM Young, DG Aregawi… - Nature …, 2020 - nature.com
… e Representative whole-well images of colony-formation assay conditions as quantified in
d. a–d n indicates number of animals or biologically independent samples (with each sample …

Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center …

…, X Xue, BM Ellingson, D Schiff, D Aregawi… - Journal of neuro …, 2012 - Springer
We have tested the predictive value of apparent diffusion coefficient (ADC) histogram analysis
in stratifying progression-free survival (PFS) and overall survival (OS) in bevacizumab-…

Idiopathic intracranial hypertension, polycystic-ovary syndrome, and thrombophilia

CJ Glueck, D Aregawi, N Goldenberg, KC Golnik… - Journal of Laboratory …, 2005 - Elsevier
We studied thrombophilia, hypofibrinolysis, and polycystic-ovary syndrome (PCOS) in 65
women consecutively referred because of idiopathic intracranial hypertension (IIH) as a means …

[PDF][PDF] Cancer stem cell assay-guided chemotherapy improves survival of patients with recurrent glioblastoma in a randomized trial

…, MJ Glantz, RM Green, A Yu, D Aregawi… - Cell Reports …, 2023 - cell.com
Therapy-resistant cancer stem cells (CSCs) contribute to the poor clinical outcomes of patients
with recurrent glioblastoma (rGBM) who fail standard of care (SOC) therapy. ChemoID is …

[HTML][HTML] Prevention of gestational diabetes by metformin plus diet in patients with polycystic ovary syndrome

CJ Glueck, J Pranikoff, D Aregawi, P Wang - Fertility and sterility, 2008 - Elsevier
… Preconception, women with body mass index (BMI) of <25 kg/m 2 and those with BMI of
≥25 (37) were respectively instructed in a 2,000 or 1,500 cal/d, high-protein (26% of calories), …

Optic neuropathy in patients with glioblastoma receiving bevacizumab

JH Sherman, DG Aregawi, A Lai… - Neurology, 2009 - AAN Enterprises
Methods. We performed a retrospective record review from 2005 to 2008 to identify adult
patients with glioblastoma receiving bevacizumab who developed severe optic neuropathy. …

A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas

Y Odia, TN Kreisl, D Aregawi, EK Innis… - Journal of neuro-oncology, 2015 - Springer
NF-kB inhibition by bortezomib enhances tamoxifen-induced apoptosis in preclinical glioma
models. We conducted a single institution, phase II trial to evaluate efficacy and safety of …

Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin …

CJ Glueck, D Aregawi, M Agloria, Q Khalil… - Clinical …, 2006 - Elsevier
… 5 and 10 mg/d in consecutively referred patients with … mg/d was administered to patients
categorized by NCEP ATP III risk stratification as moderately high risk, and rosuvastatin 10 mg/d

[HTML][HTML] Prevalence and associated factors of depressive disorder among prisoners in Mekelle General Prison Center, Tigray, Ethiopia: a cross-sectional study design

SG Welu, DH Aregawi, HT Gebreslassie… - … research and treatment, 2021 - hindawi.com
Background. Depression is the most prevalent mental disorder among prisoners and is the
second leading cause of disability worldwide. Depression affects more for those who are less …